Disclosures for "Treatment with Fremanezumab Attenuates the Association Between Weather and Headache in Participants with Episodic Migraine: A Post Hoc Analysis of the HALO-EM and HALO-LTS Studies"
-
Dr. Martin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Martin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Martin has received research support from Amgen. The institution of Dr. Martin has received research support from Eli Lilly. The institution of Dr. Martin has received research support from Teva. The institution of Dr. Martin has received research support from Abbvie. Dr. Martin has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. CohenA has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. CohenA has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. CohenA has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer . Dr. CohenA has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. CohenA has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. Dr. CohenA has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache. Dr. CohenA has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. Dr. CohenA has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Varlack Legal.
-
Dr. zhang has nothing to disclose.
-
Dr. Zhang has received personal compensation for serving as an employee of Teva. Dr. Zhang has stock in Teva.
-
Mr. Peterlin has received intellectual property interests from a discovery or technology relating to health care. Mr. Peterlin has a non-compensated relationship as a President with ERREX that is relevant to AAN interests or activities.
-
Dr. Vij has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie/Allergan. Dr. Vij has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven .
-
Dr. Ortega has received personal compensation for serving as an employee of Teva Pharmaceuticals.